For a patient with a small renal stone, is prescribing potassium citrate (Ural) together with allopurinol considered medical expulsive therapy (MET)?

No, Ural (potassium citrate) and allopurinol together is NOT considered Medical Expulsive Therapy (MET)

Medical Expulsive Therapy specifically refers to the use of alpha-adrenergic blockers (such as tamsulosin, alfuzosin, doxazosin, terazosin, or silodosin) to facilitate the spontaneous passage of ureteral stones, not renal stones. 1, 2

Understanding the Terminology

MET is exclusively for stones actively passing through the ureter:

• MET with alpha-blockers is indicated for ≤10 mm distal ureteral stones for approximately 30 days 1
• The greatest benefit is for stones >5 mm in the distal ureter 2
• MET increases likelihood of spontaneous stone passage, reduces pain, and decreases unplanned healthcare encounters 1

What Ural and Allopurinol Actually Do

Potassium citrate (Ural) and allopurinol are metabolic stone prevention therapies, not expulsive therapies:

Potassium Citrate:

• Indicated for recurrent calcium stones with low urinary citrate 3
• Used for uric acid stones to raise urinary pH to 6.0 3
• Works by alkalinizing urine and inhibiting calcium phosphate crystallization 3
• Can dissolve existing uric acid stones through oral chemolysis 2

Allopurinol:

• Indicated for recurrent calcium oxalate stones with hyperuricosuria (>800 mg/day) and normal urinary calcium 3
• NOT recommended as first-line therapy for uric acid stones 3, 4
• Reduces uric acid production but doesn't address low urinary pH, the primary driver of uric acid stones 3
• FDA-approved for recurrent calcium oxalate calculi with daily uric acid excretion >800 mg/day (males) or >750 mg/day (females) 5

Critical Clinical Pitfalls

Common mistakes to avoid:

1. Using these medications for acute stone passage: Neither potassium citrate nor allopurinol will help a small renal stone pass. They prevent future stone formation, not facilitate current stone expulsion.

2. Prescribing without metabolic evaluation: These medications should be based on 24-hour urine analysis showing specific abnormalities (hypocitraturia, hyperuricosuria) 3, 6

3. Combining allopurinol with potassium citrate without indication: Recent evidence shows no therapeutic advantage of adding allopurinol to potassium citrate for non-opaque stones 7

4. Using allopurinol for uric acid stones first-line: Urinary alkalinization with potassium citrate is the correct first-line therapy 3, 8

Appropriate Management Algorithm for Small Renal Stones

For a patient with a small renal stone:

1. If asymptomatic and <15 mm: Active surveillance with follow-up imaging is acceptable 9, 2

2. If the stone moves to the ureter and is ≤10 mm: Offer MET with alpha-blockers for ~30 days 1

3. For stone prevention after passage or removal:

   • Obtain 24-hour urine collection within 6 months 3
   • Prescribe potassium citrate if hypocitraturia is present 3
   • Add allopurinol only if hyperuricosuria (>800 mg/day) with normocalciuria 3

4. For uric acid stones specifically: Potassium citrate to achieve urine pH 6.0-6.8 is first-line; allopurinol is reserved for persistent hyperuricosuria 8

The combination you describe is metabolic stone prevention therapy for recurrent stone formers with specific urinary abnormalities, not MET for facilitating passage of an existing small renal stone.